SOMERSET, N.J., March 16, 2023 (GLOBE NEWSWIRE) -- CareCloud, Inc. (the “Company”) (Nasdaq: CCLD, CCLDP, CCLDO), a leader in healthcare technology solutions for medical practices and health systems nationwide, announced today that CFO, Bill Korn, will host investor meetings on March 21 and 22, 2023 at the KeyBanc Life Sciences & MedTech Investor Forum, being held virtually, and will hold a fireside chat with Scott Schoenhaus, KeyBanc’s Managing Director Equity Research, Healthcare IT, on Tuesday, March 21, 2023 at 12:00 p.m. EDT.
To view the fireside chat, please visit CareCloud’s investor relations site at ir.carecloud.com/events, and click on KeyBanc Life Sciences & MedTech Investor Forum.
To arrange a one-on-one meeting, investors can contact Lindsay Hummel of KeyBanc at This email address is being protected from spambots. You need JavaScript enabled to view it. or CareCloud’s investor relations firm ICR Westwicke at This email address is being protected from spambots. You need JavaScript enabled to view it..
About CareCloud
CareCloud (Nasdaq: CCLD, CCLDP, CCLDO) brings disciplined innovation to the business of healthcare. Our suite of technology-enabled solutions helps clients increase financial and operational performance, streamline clinical workflows and improve the patient experience. More than 40,000 providers count on CareCloud to help them improve patient care while reducing administrative burdens and operating costs. Learn more about our products and services including revenue cycle management (RCM), practice management (PM), electronic health records (EHR), business intelligence, telehealth and patient experience management (PXM) at www.carecloud.com.
Follow CareCloud on LinkedIn, Twitter and Facebook.
For additional information, please visit our website at www.carecloud.com. To view CareCloud’s latest investor presentations, read recent press releases, and listen to interviews with management, please visit ir.carecloud.com.
SOURCE CareCloud
Company Contact:
Bill Korn
Chief Financial Officer
CareCloud, Inc.
This email address is being protected from spambots. You need JavaScript enabled to view it.
Investor Contact:
Asher Dewhurst
ICR Westwicke
This email address is being protected from spambots. You need JavaScript enabled to view it.
Media Inquiries:
Alexis Feinberg
ICR Westwicke
This email address is being protected from spambots. You need JavaScript enabled to view it.
| Last Trade: | US$1.12 |
| Daily Change: | -0.04 -3.45 |
| Daily Volume: | 10,575 |
| Market Cap: | US$18.050M |
April 17, 2024 March 26, 2024 March 21, 2024 March 11, 2024 February 22, 2024 | |
Chimerix is on a mission to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases. The company is devoted to filling gaps in the treatment paradigm. Chimerix’s most advanced clinical-stage program is in development for H3 K27M-mutant glioma....
CLICK TO LEARN MORE
Amneal Pharmaceuticals is a fully-integrated essential medicines company. We make healthy possible through the development, manufacturing, and distribution of generic and specialty pharmaceuticals. The Company has a diverse portfolio of over 250 products in its Generics segment and is expanding across...
CLICK TO LEARN MORE
